Kitea Health is a medical technology company transforming healthcare by enabling early intervention through pressure-guided management of chronic disease.

Spun out of the renowned Auckland Bioengineering Institute in New Zealand and backed by more than 20 years of scientific research, the Kitea system is powered by the world’s most accurate micro-implantable device that facilitates remote management for heart failure and hydrocephalus.

The primary focus is on reducing costs and improving clinical outcomes in for chronic health conditions. Our first clinical indication is for hydrocephalus and brain pressure monitoring to indicate shunt failure with secondary indications in heart failure.

With easy, regular pressure measurements taken at home or in hospital, Kitea builds a rich, personalised patient profile that identifies trends and provides valuable insights, guiding physicians to make informed decisions for their patients.

Through the next generation of micro-implantable devices, Kitea eliminates guesswork, delivers greater control in chronic condition management, reducing healthcare burden, and alleviates anxiety for patients and their families.